The Zonulin Test Truth: What Your "Leaky Gut" Result Actually Measures (2026)
Somebody in a Facebook group tells you to get your zonulin checked. You order a $150 panel, spit or bleed into a tube, and three weeks later a PDF arrives with a number and a red bar next to it.
High zonulin. Leaky gut confirmed. Time to buy the protocol.
What is zonulin supposed to measure?
In 2009, Alessio Fasano's group at the University of Maryland published a paper in PNAS identifying human zonulin as pre-haptoglobin-2, the uncleaved precursor of a common blood protein. They showed it could loosen the tight junctions between intestinal cells, which is the physical seam that decides what crosses from your gut into your bloodstream.1
The logic that followed was simple. If zonulin opens tight junctions, and you can measure zonulin in blood, then blood zonulin should tell you how open your gut is. Diagnostic companies built ELISA kits on that premise and started selling them to functional medicine clinics.
Why do researchers say the zonulin test is broken?
In 2018, a German group published a study in Frontiers in Endocrinology that should have ended the conversation.
They measured serum zonulin in 376 people from the Sorbs cohort, a well-characterized German population, and genotyped every participant's haptoglobin gene. Here's the part that matters: roughly 15% of people carry the HP1-1 genotype, which means they cannot produce pre-haptoglobin-2 at all. No pre-HP2, no zonulin.
Those people still got zonulin readings. Zonulin concentrations showed no relationship to haptoglobin genotype whatsoever.2
So the researchers ran the obvious control. They fed the ELISA kit increasing concentrations of recombinant pre-haptoglobin-2, the exact protein it claims to detect. The kit didn't detect it. Then they used mass spectrometry and Western blot with the kit's own antibodies to figure out what it was binding to, and landed on properdin, a complement system protein.2
A separate Australian team at Monash reached the same destination by a different road. Publishing in PLoS One in 2019, Ajamian and colleagues ran two commercial kits through mass spectrometry and found the CUSABIO assay's top antigen matches were haptoglobin and complement C3, while the Immundiagnostik assay was picking up complement C3.3
What did the kits actually detect?
| Study | Method | What the assay detected | Evidence type |
|---|---|---|---|
| Scheffler 2018 (Front Endocrinol) | ELISA vs. genotype, mass spec, Western blot | Properdin. Did not detect recombinant pre-HP2 | Human, 376 participants |
| Ajamian 2019 (PLoS One) | Mass spectrometry on two commercial kits | Haptoglobin and complement C3 | Human serum |
What does zonulin's discoverer say about all this?
Fasano responded in Gut in 2021, and his answer is more interesting than a flat denial.
He argued that the commercial ELISAs are picking up proteins that are structurally and functionally related to the zonulin he originally described, and proposed calling the whole group "zonulin family peptides," or ZFPs.5 The German group's reply, published in the same journal, was that renaming the problem doesn't solve it.4
What you can't do is take a single number off a consumer panel and read it as a measurement of your intestinal permeability. The assay hasn't earned that.
Is fecal zonulin any better than the blood test?
Fecal zonulin shows up on a lot of stool panels now, marketed as the more direct version. The data is thinner than the marketing.
A 2025 prospective cohort in Medicina evaluated fecal zonulin in 52 participants and found its diagnostic performance fell short of what you'd want from a standalone biomarker. At the threshold that maximized accuracy, 57.0 ng/mL, sensitivity was 68.2% and specificity was 63.3%.6
Put plainly: roughly a third of people with the condition tested negative, and roughly a third without it tested positive. The authors were appropriately careful, suggesting it might contribute something inside a larger panel.
How do researchers actually measure intestinal permeability?
The method that's held up since the 1970s is the lactulose-mannitol test.
You fast, drink a solution containing both sugars, then collect urine for several hours. Mannitol is small and crosses through the cells. Lactulose is larger and only gets through if the junctions between cells are loose. Neither sugar is metabolized, so whatever shows up in your urine got there by crossing your gut wall. The ratio between them is the readout.7
It's slow, it's inconvenient, and it mostly lives in research settings rather than consumer testing.
So what should you do instead of buying a zonulin test?
Skip the standalone consumer zonulin panel. Whatever the number says, you won't be able to act on it with any confidence. If a practitioner has ordered it as one input among many and can explain the caveats, that's a different situation.
Take symptoms seriously even without a biomarker. Bloating, urgency, food reactions, and fatigue are real whether or not a test confirms them. The absence of a validated blood marker doesn't mean the absence of a problem. Talk to a gastroenterologist, especially if symptoms are new or worsening.
Feed the parts of the system we understand better. The gut barrier's energy economy is far better characterized than any single blood marker of it. Roediger showed back in 1980, using isolated human colonocytes, that butyrate is the primary respiratory fuel for the cells lining the colon.8 That finding has held up for over four decades.
Fiber that reaches your colon feeds the bacteria that make butyrate. More on the practical routes in our guide to increasing butyrate naturally, and the broader context in leaky gut and inflammation.
Where does Ozzi fit into this?
Ozzi Crave Crusher contains 500mg of L-Lysine Butyrate per stick. Butyrate is the primary energy source for the cells lining your colon. That's a structure/function statement, and it's the honest limit of what I'll claim.
What I won't tell you: that Ozzi seals a leaky gut, lowers your zonulin, or fixes your intestinal barrier. There are zero human randomized trials on L-Lysine Butyrate. The GLP-1 mechanism people cite for butyrate comes from mouse and cell studies, and a human trial that successfully raised circulating butyrate measured GLP-1 as a secondary outcome and found no change. We cover that honestly in butyrate and GLP-1 and our butyrate supplement picks.
Most people buy Ozzi for a much more concrete reason: the 9pm thing. Night cravings, food noise, the monster that comes out after a day of eating well. That's what the 8g of allulose and 500mg of glucomannan are doing, and it has nothing to do with your gut barrier.
If you want the fuller picture of how the microbiome connects to appetite, start with gut health and GLP-1 and the gut-brain axis. And if you enjoyed watching a popular gut claim get taken apart, we did the same thing to the "95% of serotonin is in your gut" stat and to prebiotic fiber's appetite claims.
Skip the test. Try the thing.
500mg butyrate, 8g allulose, and no claims we can't back up. 14-Day Ozzi Challenge: Take it for 14 straight days. If your cravings and food noise aren't quieter, we'll refund your first bag.
Frequently asked questions
What does a high zonulin result mean?
A high zonulin result means a group of blood proteins the assay binds to was elevated. Some of those, like complement C3 and haptoglobin, rise with general inflammation. It does not confirm that your intestinal barrier is leaking.
Is leaky gut real?
Increased intestinal permeability is a real, measurable phenomenon documented in celiac disease, Crohn's, and several other conditions. The disagreement is about whether one commercial blood test can measure it, and whether "leaky gut syndrome" as sold online is a coherent diagnosis.
Does butyrate lower zonulin?
We wouldn't make that claim, and neither should anyone selling you butyrate. Since the assay's validity is disputed, a change in the number wouldn't clearly mean anything anyway. Butyrate's best-established role is as the primary energy source for colon cells.
References
- Tripathi A, Lammers KM, Goldblum S, et al. Identification of human zonulin, a physiological modulator of tight junctions, as prehaptoglobin-2. Proc Natl Acad Sci U S A. 2009;106(39):16799-16804. doi:10.1073/pnas.0906773106 (PMID: 19805376)
- Scheffler L, Crane A, Heyne H, et al. Widely Used Commercial ELISA Does Not Detect Precursor of Haptoglobin2, but Recognizes Properdin as a Potential Second Member of the Zonulin Family. Front Endocrinol. 2018;9:22. doi:10.3389/fendo.2018.00022 (PMID: 29459849)
- Ajamian M, Steer D, Rosella G, Gibson PR. Serum zonulin as a marker of intestinal mucosal barrier function: May not be what it seems. PLoS One. 2019;14(1):e0210728. doi:10.1371/journal.pone.0210728 (PMID: 30640940)
- Massier L, Chakaroun R, Kovacs P, Heiker JT. Blurring the picture in leaky gut research: how shortcomings of zonulin as a biomarker mislead the field of intestinal permeability. Gut. 2021;70(9):1801-1802. doi:10.1136/gutjnl-2020-323026
- Fasano A. Zonulin measurement conundrum: add confusion to confusion does not lead to clarity. Gut. 2021;70(10):2007-2008. doi:10.1136/gutjnl-2020-323367 (PMID: 33177164)
- Fecal Zonulin as a Non-Invasive Marker of Intestinal Permeability: Findings from a Prospective Cohort Study. Medicina (Kaunas). 2025. PMC12471543
- Biomarkers for assessment of intestinal permeability in clinical practice. Am J Physiol Gastrointest Liver Physiol. 2021;321(3). doi:10.1152/ajpgi.00113.2021 (PMID: 34009040)
- Roediger WEW. Role of anaerobic bacteria in the metabolic welfare of the colonic mucosa in man. Gut. 1980;21(9):793-798. doi:10.1136/gut.21.9.793 (PMID: 7429343)
